Almost Family, Inc. (AFAM) continues to quietly beat estimates and grow revenues. Third quarter estimates have risen in the last 30 days.

Almost Family provides home health nursing, rehabilitation and personal care services. It has surprised on estimates 7 quarters in a row and has beat on average of 15.42% in the last four.

On Aug 5, the company reported second quarter results which saw revenues rise 54% to $74.9 million from $48.7 million in the year ago period. The company surprised on the Zacks Consensus Estimate by 8.96% as earnings per share were 73 cents compared to the estimate of 67 cents. Almost Family reported 50 cents in the year ago period.

The Visiting Nursing segment saw 65% growth compared to the second quarter of 2008, with 29% of that coming from organic growth and the rest from acquisitions. The Personal Care segment increased 11%.

Will the company’s earnings surprise streak continue in the third quarter? Almost Family is scheduled to report earnings on Nov 4. The Zacks Consensus Estimate is up 1 cent to 70 cents in the last 30 days. Analysts expect 2009 earnings growth of 30.81%.

Value Fundamentals

Almost Family is a Zacks #2 Rank (buy) stock. When I last reviewed the company in April 2009, it was trading at only 6.6x forward earnings. It is more expensive now, at 11.2x forward earnings, but still well within the value parameters.

The company has a low PEG ratio of 0.56. It also has a stellar 1-year return on equity (ROE) of 22.11%.

Read the April article.

Update to Previous Value Zacks Rank Buy Stocks

The Lubrizol Corporation (LZ) has seen its stock hitting 52-week highs in recent sessions, but it’s still an attractive value stock as earnings have been rising. LZ has a forward P/E of just 11.33. Read the full article.

SYNNEX Corporation (SNX) surprised on estimates for the 8th quarter in a row in September as sales grew quarter over quarter. The company is cheap, trading with a price-to-book ratio of just 1.25. Read the full article.

Corinthian Colleges Inc. (COCO) has surprised on estimates the last 3 quarters in a row by an average of 25.09% as enrollment has soared. The company has both growth and value characteristics. It has a PEG ratio of just 0.7. Read the full article.

Covidien Limited (COV) has surprised on estimates 3 out of the last 4 quarters. The company also recently raised its dividend. Covidien is trading at 13.6x forward earnings. Read the full article.

Zacks Investment Research